A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer
Lists
Only you see this
Abstract
Our results support the consideration of Lauren subtype when prescribing systemic chemotherapy for GC, particularly for MGC or DGC, which may not benefit from chemotherapy. Lauren classification should be considered to stratify chemotherapy regimens to GC patients in future clinical trials, with particular relevance to MGC or DGC, which is more difficult to treat with current regimens.
BibTeX
@inproceedings{wang2020cohort,
author = {Kunning Wang and Enxiao Li and Rita A. Busuttil and Joseph C. Kong and Sharon Pattison and Joseph J.�Y. Sung and Jun Yu and Emad El‐Omar and J. A. Simpson and Alex Boussioutas},
title = {{A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer}},
booktitle = {Therapeutic},
year = {2020},
doi = {10.1177/1758835920930359},
}Loading related content...